SG48806A1 - Method of combating acyclovir-resistant herpes simplex viral infections - Google Patents

Method of combating acyclovir-resistant herpes simplex viral infections

Info

Publication number
SG48806A1
SG48806A1 SG1996001910A SG1996001910A SG48806A1 SG 48806 A1 SG48806 A1 SG 48806A1 SG 1996001910 A SG1996001910 A SG 1996001910A SG 1996001910 A SG1996001910 A SG 1996001910A SG 48806 A1 SG48806 A1 SG 48806A1
Authority
SG
Singapore
Prior art keywords
acyclovir
combating
herpes simplex
viral infections
simplex viral
Prior art date
Application number
SG1996001910A
Other languages
English (en)
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of SG48806A1 publication Critical patent/SG48806A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996001910A 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections SG48806A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (1)

Publication Number Publication Date
SG48806A1 true SG48806A1 (en) 1998-05-18

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001910A SG48806A1 (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Country Status (13)

Country Link
EP (1) EP0767671A1 (no)
JP (1) JPH08509476A (no)
KR (1) KR960701651A (no)
CN (1) CN1126438A (no)
AU (1) AU683465B2 (no)
BR (1) BR9406575A (no)
CA (1) CA2095408A1 (no)
CZ (1) CZ287795A3 (no)
HU (1) HUT73779A (no)
NO (1) NO954390L (no)
SG (1) SG48806A1 (no)
SK (1) SK132695A3 (no)
WO (1) WO1994025046A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (zh) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
CZ287795A3 (en) 1996-06-12
HUT73779A (en) 1996-09-30
CA2095408A1 (en) 1994-11-04
CN1126438A (zh) 1996-07-10
NO954390D0 (no) 1995-11-02
KR960701651A (ko) 1996-03-28
AU6642394A (en) 1994-11-21
WO1994025046A1 (en) 1994-11-10
SK132695A3 (en) 1996-10-02
AU683465B2 (en) 1997-11-13
EP0767671A1 (en) 1997-04-16
BR9406575A (pt) 1996-03-19
HU9503135D0 (en) 1996-01-29
JPH08509476A (ja) 1996-10-08
NO954390L (no) 1996-01-02

Similar Documents

Publication Publication Date Title
AU6774294A (en) Methods of preventing viral replication
AU4772493A (en) Sulfo-derivatives of adenosine
PL299412A1 (en) Novel purine nucleosides, novel intermediate compounds and pharmaceutical preparation
PL309610A1 (en) Purine derivatives
AU5758594A (en) Treatment of viral infections
EP0862445B8 (en) Combination of herpes simplex virus and chemotherapy for treating cancer
AU4688696A (en) Drugs to prevent recurrent herpes virus infections
EP0526652A4 (en) Method of type-specific detection of herpes simplex virus
SG48806A1 (en) Method of combating acyclovir-resistant herpes simplex viral infections
AU9079491A (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
AU2591692A (en) Method of treating latent herpes viral infections
HK1016475A1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
AU8334691A (en) Antiviral agent
GB9419692D0 (en) Treatment of herpes infections
IL65783A0 (en) Pharmaceutical composition for combating herpes simplex viruses types i and ii
AU3170293A (en) Therapeutic nucleosides
AU4257896A (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpes virus infections
AU4508493A (en) Therapeutic nucleosides
AU4751496A (en) Herpes simplex virus mutants
AU7389794A (en) Therapeutic combination containing an anti-varicella zoster virus compound and lamotrigine
AU4167293A (en) Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents
AU5960794A (en) Compositions effective against acyclovir-resistant strains of herpes viruses
AU3512793A (en) Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
AU3395993A (en) Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use